Page last updated: 2024-10-29

indomethacin and Latent Tuberculosis

indomethacin has been researched along with Latent Tuberculosis in 1 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Latent Tuberculosis: The dormant form of TUBERCULOSIS where the person shows no obvious symptoms and no sign of the causative agent (Mycobacterium tuberculosis) in the SPUTUM despite being positive for tuberculosis infection skin test.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tonby, K1
Wergeland, I1
Lieske, NV1
Kvale, D1
Tasken, K1
Dyrhol-Riise, AM1

Other Studies

1 other study available for indomethacin and Latent Tuberculosis

ArticleYear
The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection.
    BMC infectious diseases, 2016, Oct-24, Volume: 16, Issue:1

    Topics: Adolescent; Adult; Aged; Antigens, Bacterial; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Cytokines

2016